Record half-year results driven by a €25.5M gain from the Trade Republic share sale, with net profit at €26.6M and equity ratio at 91.5%. Full-year net profit is projected at €40.8M–€41.6M, with a dividend of at least €14.80 per share planned.Original document: sino Aktiengesellschaft [XTP] Interim…
The meeting approved the 2025 annual report, covered the net loss from retained earnings, and endorsed Management Board remuneration principles. Despite a net loss in 2025, the outlook for 2026 is strong with significant revenue and profit growth expected, supported by a robust development pipeline…
The acquisition of VigilAigent brings immediate recurring revenue, expands commercial reach, and integrates advanced AI-driven cybersecurity capabilities. The deal is expected to accelerate growth, improve margins, and position the combined entity as a differentiated leader in the evolving security…
Stockholders approved both the merger with The Brink's Company and the related executive compensation proposal. Quorum was established with over 80% of votes represented, and final vote counts will be disclosed in a forthcoming SEC filing.Based on NCR Atleos Corporation [NATL] AGM 2026 Audio Transc…
The meeting was held virtually to enhance shareholder engagement and reduce costs. All nine resolutions were put to a poll, with results to be announced after tallying. No questions were raised by shareholders during the session.Based on RedCloud Holdings plc [RCT] AGM 2026 Audio Transcript — Jun…
The meeting reconvened virtually, established quorum, and addressed four key proposals, including director elections, auditor ratification, a reverse stock split, and adjournment flexibility. All proposals passed, and management addressed concerns about private equity partnerships.Based on Edible G…
The meeting established a quorum and approved both the merger with The Brink's Company and the related executive compensation proposal. Final vote counts will be disclosed in a forthcoming SEC filing.Based on NCR Atleos Corporation [NATL] AGM 2026 Audio Transcript — Jun. 30 2026This is an AI-genera…
A special meeting was held to approve a share issuance related to a merger with NCR Atleos Corporation. With a quorum of 91.63% present, the proposal passed and final results will be filed with the SEC.Based on Brinks Company (The) [BCO] AGM 2026 Audio Transcript — Jun. 30 2026This is an AI-generat…
The meeting covered director elections, executive compensation, auditor ratification, and governance amendments. All proposals passed, with final results to be filed with the SEC. No questions were raised during the Q&A.Based on MongoDB, Inc. [MDB] AGM 2026 Audio Transcript — Jun. 30 2026This is an…
Customer confidence and B2B volumes are rising, with strong machine sector performance but ongoing challenges in furniture. M&A targets are significant, financing is secured, and leverage reduction is on track. AI-driven cost initiatives and a bond buyback support efficiency and shareholder value…
The Ema Rare Earth Project's bankable feasibility study confirms robust economics with a post-tax NPV8 of US$1.47B, IRR of 105%, and a 6-month payback, supported by low capex and operating costs. ISR mining, advanced permitting, and strong ESG credentials position the project as a leading low-cost…
The Ema Rare Earth Project targets a 20-year mine life with a large, scalable resource and low-cost, high-return profile. With a post-tax NPV of US $1.47B, IRR of 105%, and rapid payback, it offers strong financial returns, robust ESG credentials, and resilience to price fluctuations.Original docum…
A transformational all-stock merger will create a diversified leader in outdoor enthusiast, housing, and transportation markets, with $8.1B in revenue and $1B in EBITDA. The deal targets $150M in annual cost synergies, robust aftermarket growth, and enhanced innovation, with closing expected in H1…
Two complementary component solutions providers will merge in an all-stock deal, creating a diversified platform for outdoor, housing, and transportation markets. The combined entity expects over $150 million in cost synergies within three years and aims for enhanced growth and stability.Original d…
A transformational all-stock merger will unite two complementary manufacturers, creating a diversified platform with $8.1B in revenue, $1B in EBITDA, and $150M in annual cost synergies. The deal enhances innovation, expands aftermarket reach, and is expected to be accretive in year one.Based on Pat…
Rebranding to Cerenome reflects a broader CNS oncology focus, integrating therapeutics, diagnostics, and AI-driven data. REYOBIQ and CNSide platforms are advancing on all 2026 objectives, with payer coverage, clinical trial progress, and AI initiatives on track to drive operational efficiency and g…
The PALISADE-4 Phase 3 trial of fasedienol for social anxiety disorder did not meet primary or secondary endpoints in the overall population, but post-hoc analyses showed significant benefit in patients with very severe anxiety. Favorable safety data and pooled analyses support plans to pursue a ne…
PALISADE-4 did not meet primary or secondary endpoints in the overall population, but post-hoc analyses showed significant benefit for fasedienol in patients with very severe social anxiety disorder. Safety remained favorable, and plans are underway to pursue an LSAS-based registrational pathway wi…
Revenue and EBITDA surged on strong demand for high-end substrates, driven by AI and HPC trends. Major capacity expansion in Malaysia is client-funded, reducing financial risk. Guidance calls for ~50% revenue growth and higher margins, with positive cash flow and deleveraging focus.Based on AT & S…
A differentiated CAR T-cell therapy shows strong safety and efficacy in real-world and clinical settings, with expanding adoption and revenue growth. Ongoing studies target broader oncology and autoimmune indications, with key data readouts expected through 2028.Based on Autolus Therapeutics plc [A…
